Works about GLUCAGON-like peptide-1 receptor

Results: 2059

Temporal changes in mediation effects on cardiovascular and microvascular outcomes with glucagon-like peptide-1 receptor agonist therapy: a post-hoc analysis of the LEADER trial.

Published in:

Cardiovascular Research, 2025, v. 121, n. 1, p. 10, doi. 10.1093/cvr/cvae237

By:

Peng, Zi-Yang;
Lee, Yu-Hsuan;
Ou, Huang-Tz;
Kuo, Shihchen

Publication type:

Article

Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States: A Population-Based Cohort Study.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 5, p. 620, doi. 10.7326/ANNALS-24-02870

By:

Ostrominski, John W.;
Ortega-Montiel, Janinne;
Tesfaye, Helen;
Alix, Caroline;
DiCesare, Elyse;
Cromer, Sara J.;
Wexler, Deborah J.;
Paik, Julie M.;
Patorno, Elisabetta

Publication type:

Article

Applicability of multiple quantitative ultrasound liver biomarkers in children and adolescents with severe obesity.

Published in:

BMC Pediatrics, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12887-025-05750-1

By:

Cetinic, Ivan;
de Lange, Charlotte;
Lagerstrand, Kerstin;
Kindblom, Jenny M.;
Sjögren, Lovisa;
Hebelka, Hanna

Publication type:

Article

Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future.

Published in:

Diabetes Therapy, 2025, v. 16, n. 6, p. 1155, doi. 10.1007/s13300-025-01738-3

By:

Fernando, Kevin;
Connolly, Derek;
Darcy, Eimear;
Evans, Marc;
Hinchliffe, William;
Holmes, Patrick;
Strain, W. David

Publication type:

Article

The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy.

Published in:

Diabetes Therapy, 2025, v. 16, n. 6, p. 1077, doi. 10.1007/s13300-025-01712-z

By:

Panou, Theodoros;
Gouveri, Evanthia;
Popovic, Djordje S.;
Papazoglou, Dimitrios;
Papanas, Nikolaos

Publication type:

Article

Cost-utility of IDegLira versus alternative basal insulin intensification therapies in patients with type 2 diabetes mellitus uncontrolled on basal insulin in a Chinese setting.

Published in:

Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-025-01722-8

By:

Weng, Junling;
Xiao, Dunming;
Chen, Yingyao

Publication type:

Article

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

New treatments and biomarkers in heart failure, hypertrophic cardiomyopathy, and familial hypercholesterolaemia Free.

Published in:

European Heart Journal, 2025, v. 46, n. 19, p. 1777, doi. 10.1093/eurheartj/ehaf271

By:

Crea, Filippo

Publication type:

Article

Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies.

Published in:

European Heart Journal, 2025, v. 46, n. 19, p. 1849, doi. 10.1093/eurheartj/ehae931

By:

Watts, Gerald F;
Chan, Dick C

Publication type:

Article

Effects of patient age on the therapeutic effects of GIP/GLP-1 receptor agonists (tirzepatide).

Published in:

Drug Discoveries & Therapeutics, 2025, v. 19, n. 2, p. 133, doi. 10.5582/ddt.2025.01012

By:

Atsushi Ishimura;
Yutaka Shimizu;
Naohiro Yabuki

Publication type:

Article

Clinical studies on anti-obesity medications in Arab countries.

Published in:

Saudi Medical Journal, 2025, v. 46, n. 5, p. 459, doi. 10.15537/smj.2025.46.5.20250126

By:

AlOtaibi, Haifa F.;
Al Taib, Hanan N.;
AlMuhaidib, Shadan;
Alshagrawi, Saud;
Almufarrih, Abdulmalik;
Alalmai, Ola;
Alnaserallah, Sahar;
Alodah, Najla;
Alqahtani, Saleh A.;
Alhazzani, Waleed

Publication type:

Article

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization.

Published in:

BMC Psychiatry, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12888-025-06914-0

By:

Zhang, Lingfeng;
Chen, Xiang;
Xu, Yantao;
Liu, Jiachen;
Liu, Zhongchun

Publication type:

Article

Glucagon-like Peptide-1 Receptor Agonists in the Context of Eating Disorders: A Promising Therapeutic Option or a Double-Edged Sword?

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 3122, doi. 10.3390/jcm14093122

By:

Kałas, Maria;
Stępniewska, Ewelina;
Gniedziejko, Michał;
Leszczyński-Czeczatka, Jakub;
Siemiński, Mariusz

Publication type:

Article

Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 3083, doi. 10.3390/jcm14093083

By:

Abrignani, Maurizio Giuseppe;
Lucà, Fabiana;
Abrignani, Vincenzo;
Nucara, Mariacarmela;
Grosseto, Daniele;
Lestuzzi, Chiara;
Mistrangelo, Marinella;
Passaretti, Bruno;
Rao, Carmelo Massimiliano;
Parrini, Iris

Publication type:

Article

Genetic Risk Score Identifies Individuals Likely to Report Adverse Events from GLP-1 Mimetic Therapy.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP Study.

Published in:

Tokai Journal of Experimental & Clinical Medicine, 2025, v. 50, n. 1, p. 1

By:

Yoshimi MUTA;
Kazuo KOBAYASHI;
Masao TOYODA;
Shunichiro TSUKAMOTO;
Daisuke TSURIYA;
Yuichi TAKASHI;
Hisashi YOKOMIZO;
Kei TAKESHITA;
Takuya HASHIMOTO;
Moritsugu KIMURA;
Kouichi TAMURA;
Keizo KANASAKI;
Daiji KAWANAMI

Publication type:

Article

Broadening Horizons with GLP-1 Receptor Analogues as an Adjunct to Bariatric Metabolic Surgery: Risk Awareness of a Possible Link to Non-arteritic Ischemic Optic Neuropathy.

Published in:

2025

By:

Varughese, Maria Susan;
Kalidindi, Sushuma

Publication type:

Editorial

Minimising harms of tight glycaemic control in older patients with type 2 diabetes.

Published in:

African Journal of Primary Health Care & Family Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.4102/phcfm.v16i1.4857

By:

Thompson, Wade

Publication type:

Article

The effect of semaglutide on intestinal iron absorption in patients with type 2 diabetes mellitus—A pilot study.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3542, doi. 10.1111/dom.16368

By:

Melis, Petra;
Lucijanic, Marko;
Kranjcec, Bojana;
Cigrovski Berkovic, Maja;
Marusic, Srecko

Publication type:

Article

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3526, doi. 10.1111/dom.16349

By:

Coon, Scott A.;
White, Raechel T.;
Pagnozzi, Dominique;
Cowart, Kevin

Publication type:

Article

The extent and predictors of off‐label use of GLP‐1 receptor agonists for weight loss management.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3509, doi. 10.1111/dom.16313

By:

Siudak, Zbigniew;
Tkaczyk, Filip;
Tomaszewska, Monika;
Malinowski, Krzysztof P.;
Szarpak, Lukasz;
Kowalska‐Bobko, Iwona

Publication type:

Article

Empagliflozin versus DPP4i or GLP‐1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3503, doi. 10.1111/dom.16303

By:

Tesfaye, Helen;
Paik, Julie M.;
Zakoul, Heidi;
Schmedt, Niklas;
Wexler, Deborah J.;
Patorno, Elisabetta

Publication type:

Article

GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.

Published in:

Acta Diabetologica, 2024, v. 61, n. 2, p. 225, doi. 10.1007/s00592-023-02184-y

By:

Li, Xiang;
Jiang, Xiao;
Jiang, Mei;
Wang, Zhi-feng;
Zhao, Tao;
Cao, Si-ming;
Li, Qiu-Mei

Publication type:

Article

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.

Published in:

Acta Diabetologica, 2023, v. 60, n. 11, p. 1551, doi. 10.1007/s00592-023-02135-7

By:

Oezer, Kuebra;
Kolibabka, Matthias;
Gassenhuber, Johann;
Dietrich, Nadine;
Fleming, Thomas;
Schlotterer, Andrea;
Morcos, Michael;
Wohlfart, Paulus;
Hammes, Hans-Peter

Publication type:

Article

De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.

Published in:

Acta Diabetologica, 2023, v. 60, n. 1, p. 53, doi. 10.1007/s00592-022-01974-0

By:

Falcetta, Pierpaolo;
Nicolì, Francesca;
Citro, Fabrizia;
Ciccarone, Annamaria;
Garofolo, Monia;
Del Prato, Stefano;
Bianchi, Cristina

Publication type:

Article

γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.

Published in:

Acta Diabetologica, 2023, v. 60, n. 1, p. 19, doi. 10.1007/s00592-022-01970-4

By:

Gu, Liangbiao;
Cui, Xiaona;
Lin, Xiafang;
Yang, Jin;
Wei, Rui;
Hong, Tianpei;
Yang, Kun

Publication type:

Article

Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.

Published in:

Acta Diabetologica, 2022, v. 59, n. 11, p. 1437, doi. 10.1007/s00592-022-01928-6

By:

Hernández, Cristina;
Gómez-Peralta, Fernando;
Simó-Servat, Olga;
García-Ramírez, Marta;
Abreu, Cristina;
Gómez-Rodríguez, Sara;
Simó, Rafael

Publication type:

Article

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.

Published in:

Acta Diabetologica, 2022, v. 59, n. 4, p. 519, doi. 10.1007/s00592-021-01830-7

By:

Ding, Chen;
Tang, Yaxin;
Zhu, Wenqiang;
Huang, Piaopiao;
Lian, Pingan;
Ran, Juanli;
Huang, Xiansheng

Publication type:

Article

Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes.

Published in:

Acta Diabetologica, 2021, v. 58, n. 9, p. 1281, doi. 10.1007/s00592-021-01729-3

By:

Lebbar, Maha;
Timsit, José;
Luyton, Cédric;
Marchand, Lucien

Publication type:

Article

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

Published in:

Acta Diabetologica, 2021, v. 58, n. 5, p. 595, doi. 10.1007/s00592-020-01660-z

By:

Yang, Kun;
Wang, Haining;
Wei, Rui;
Xiao, Wenhua;
Tian, Qing;
Wang, Chen;
Yang, Jin;
Hong, Tianpei

Publication type:

Article

Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.

Published in:

Acta Diabetologica, 2021, v. 58, n. 1, p. 5, doi. 10.1007/s00592-020-01542-4

By:

Jia, Shubing;
Wang, Zhiying;
Han, Ruobing;
Zhang, Zinv;
Li, Yuping;
Qin, Xiaotong;
Zhao, Mingyi;
Xiang, Rongwu;
Yang, Jingyu

Publication type:

Article

Alternative methods for assessing glycemia might prove useful in cases of discordance between glycated hemoglobin and self-monitoring of blood glucose.

Published in:

2020

By:

Koufakis, Theocharis;
Kotsa, Kalliopi

Publication type:

Letter

The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.

Published in:

Acta Diabetologica, 2020, v. 57, n. 10, p. 1129, doi. 10.1007/s00592-020-01529-1

By:

Jin, Yuxin;
Zhao, Hang;
Hou, Yilin;
Song, Guangyao

Publication type:

Article

Species differences in pancreatic binding of DO3A-VS-Cys-Exendin4.

Published in:

Acta Diabetologica, 2017, v. 54, n. 11, p. 1039, doi. 10.1007/s00592-017-1046-2

By:

Eriksson, Olof;
Rosenström, Ulrika;
Selvaraju, Ram;
Eriksson, Barbro;
Velikyan, Irina

Publication type:

Article

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

Published in:

Acta Diabetologica, 2017, v. 54, n. 10, p. 933, doi. 10.1007/s00592-017-1031-9

By:

Dicembrini, Ilaria;
Nreu, Besmir;
Scatena, Alessia;
Andreozzi, Francesco;
Sesti, Giorgio;
Mannucci, Edoardo;
Monami, Matteo

Publication type:

Article

Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide.

Published in:

2014

By:

Faurschou, A.;
Knop, F.;
Thyssen, J.;
Zachariae, C.;
Skov, L.;
Vilsbøll, T.

Publication type:

Report

Achieving glycemic control in patients with type 2 diabetes and renal impairment.

Published in:

Acta Diabetologica, 2013, v. 50, n. 3, p. 283, doi. 10.1007/s00592-012-0442-x

By:

Avogaro, Angelo;
Schernthaner, Guntram

Publication type:

Article

GLP-1 receptor agonists—another promising therapy for Alport syndrome?

Published in:

Journal of Rare Diseases, 2025, v. 4, n. 1, p. 1, doi. 10.1007/s44162-024-00065-8

By:

Boeckhaus, Jan;
Mabillard, Holly;
Sayer, John A.

Publication type:

Article

Exploring the Cytoprotective Role of Liraglutide in Non-Alcoholic Fatty Liver Disease Experimentally Induced in the Rat Model (Histological and Biochemical Study).

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 9, p. 4348, doi. 10.21608/ZUMJ.2024.321384.3582

By:

Shaban, Sahar F.;
Mohamed, Dalia A.;
Elsayed Mahmoud, Aya Ismael;
Abdel-aziz, Heba Mohamed

Publication type:

Article

The effect of incretin antidiabetic drugs on obesity, cardiovascular system, and kidneys.

Published in:

Family Medicine Forum / Forum Medycyny Rodzinnej, 2025, v. 19, n. 2, p. 46, doi. 10.5603/fmr.103000

By:

Kamińska, Monika;
Miernik-Skrzypczak, Magdalena;
Spyra, Aleksandra;
Kozioł, Aleksandra;
Marszałek-Moc, Kaja;
Malicka, Marta;
Dąbrowska, Natalia;
Chruściel, Klaudia;
Karnas-Bogacka, Patrycja;
Palacz, Karolina A.

Publication type:

Article

Вплив інкретиноміметиків на рівень мікробіального метаболіта триметиламін-N-оксиду — маркера серцево-судинного ризику у хворих на цукровий діабет 2-го типу.

Published in:

International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2023, v. 19, n. 7, p. 523, doi. 10.22141/2224-0721.19.7.2023.1330

By:

К. О., Шишкань-Шишова;
О. В., Зінич;
Н. М., Кушнарьова;
А. В., Ковальчук;
О. В., Прибила

Publication type:

Article

Innovative Glucagon-based Therapies for Obesity.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 12, p. 1, doi. 10.1210/jendso/bvae197

By:

Belay, Kibret Enyew;
Jemal, Rebil Heiru;
Tuyizere, Aloys

Publication type:

Article

Fundamental Body Composition Principles Provide Context for Fat-Free and Skeletal Muscle Loss With GLP-1 RA Treatments.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 11, p. 1, doi. 10.1210/jendso/bvae164

By:

Tinsley, Grant M;
Heymsfield, Steven B

Publication type:

Article

Chronic Semaglutide Treatment in Rats Leads to Daily Excessive Concentration-Dependent Sucrose Intake.

Published in:

Journal of the Endocrine Society, 2023, v. 7, n. 7, p. 1, doi. 10.1210/jendso/bvad074

By:

Cawthon, Carolina R;
Blonde, Ginger D;
Nisi, A Valentina;
Bloomston, Haley M;
Krubitski, Belle;
Roux, Carel W le;
Spector, Alan C

Publication type:

Article

Adverse Events Related to Tirzepatide.

Published in:

Journal of the Endocrine Society, 2023, v. 7, n. 4, p. 1, doi. 10.1210/jendso/bvad016

By:

Mishra, Rahul;
Raj, Rishi;
Elshimy, Ghada;
Zapata, Isain;
Kannan, Lakshmi;
Majety, Priyanka;
Edem, Dinesh;
Correa, Ricardo

Publication type:

Article

Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study.

Published in:

Journal of the Endocrine Society, 2022, v. 6, n. 11, p. 1, doi. 10.1210/jendso/bvac138

By:

Chan, Raymond Ngai Chiu;
Lee, Teddy Tai Loy;
Chou, Oscar Hou In;
So, Jenny;
Chung, Cheuk To;
Dee, Edward Christopher;
Ng, Kenrick;
Tang, Pias;
Roever, Leonardo;
Liu, Tong;
Wong, Wing Tak;
Tse, Gary;
Lee, Sharen

Publication type:

Article

Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM.

Published in:: 2021
Publication type:: Correction Notice

CORRIGENDUM FOR "Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM".

Published in:: 2020
Publication type:: Correction Notice

Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity.

Published in:

Journal of the Endocrine Society, 2020, v. 4, n. 4, p. N.PAG, doi. 10.1210/jendso/bvz042

By:

Iacobellis, Gianluca;
Fricke, Alexandra C Villasante

Publication type:

Article